TELA
TELA Bio, Inc.
Key Financials
Operating Income
$-33755000
↑ 1.1%
Net Income
$-38831000
↓ 2.6%
Revenue
$80.3M
↑ 15.8%
Gross Profit
$54.3M
↑ 16.9%
EPS (Diluted)
$-0.83
↑ 37.6%
Total Assets
$81.4M
↓ 6.0%
Total Liabilities
$75.1M
↑ 29.2%
Cash & Equivalents
$50.8M
↓ 3.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 8/17/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 8-K/A | 8/13/2026 | View on SEC |
| S-8 | 8/11/2026 | View on SEC |
| 10-Q | 8/11/2026 | View on SEC |
| SCHEDULE 13G | 8/11/2026 | View on SEC |
| 8-K | 8/10/2026 | View on SEC |
| 4 | 8/5/2026 | View on SEC |
| 3 | 8/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | TELA |
| Company Name | TELA Bio, Inc. |
| CIK | 1561921 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 484-320-2930 |